Tirzepatida (Mounjaro): en el ensayo SURMOUNT-1, la prdida de peso media fue del 22,5% con las dosis mximas tras 72 semanas de tratamiento
GLP-1s may become part of a larger prevention conversation for some patients in the future, said Gary, but they are not a replacement for screening, risk assessment, or individualized medical guidance. While GLP-1s may play a future role in breast cancer prevention, Mia Kazanjian, MD, a board certified radiologist and director of Womens Imaging at Norwalk Radiology Consultants, said there are several steps women can take right now to help reduce their risk
Diabetes Care 2020, 43, S89S97
These benefits remain as long as they keep the weight off
Most patients see results within 4 to 6 weeks
Defining optimal cost-effective approaches to care, particularly in the management of patients (multi-morbidity), is essential